Leading drug firm Roche has reportedly formed a partnership with India’s Wellthy Therapeutics to provide its users with the Accu-Check Active system, an artificial intelligence-related digital diabetes coaching solution.
As per trusted sources, the joint offering of the two companies will include the Accu-Check Active blood and glucose meter, and the Wellthy Care mobile application for the new users. The bundle will be launched in the southern as well as the western parts of India.
Rahul Kedia, Ad-Interim General Manager of Roche Diabetes Care India, was quoted saying that Wellthy’s digital diabetes health coach will now enable users to log blood glucose readings directly into the app. This will help the user receive guidance on understanding and managing their diabetes at all times. He further added that the company firmly believes that these joint offerings will aid in improving the quality of life for Indians with type 2 diabetes.
In a news report by Silicone India, Kedia even stated that India is home to the second largest number of diabetes patients in the world. According to the International Diabetes Foundation, the number equaled almost 73 million in 2017. Therefore, there is a real need for those patients to be able to regularly monitor their blood and glucose levels and be recipients of support for their efforts to keep diabetes under control.
Abhishek Shah, Co-founder & CEO of Wellthy Therapeutics, said in a statement that the partnership marks an important step in a much larger shared vision that can bring a meaningful difference to the lives of millions of people suffering from diabetes.
For the record, Roche Diabetes Care is a global leader in integrated diabetes management, which works with healthcare providers and caregivers to manage this health condition and be a part of the sustainable care structures. The firm is committed to improving patient’s access to medical innovations by collaborating with relevant stakeholders.
